{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:38:53Z","timestamp":1791848333075,"version":"4.3.4"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T00:00:00Z","timestamp":1662336000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001348","name":"Agency for Science, Technology and Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001348","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>The World Health Organization has defined long COVID-19 (LC) as a condition that occurs in individuals with a history of SARS-CoV-2 infection who exhibit persistent symptoms after its acute phase that last for at least two months and cannot be explained by an alternative diagnosis. Since we had previously reported residual viral antigens in tissues of convalescent patients, we aimed to assess the presence of such antigens in long COVID tissues.\u00a0Here, we established the presence of the residual virus in the appendix, skin, and breast tissues of 2 patients who exhibited LC symptoms 163 and 426 days after symptom onset. With multiplex immunohistochemistry, we detected viral nucleocapsid protein in all three tissues. The nucleocapsid protein was further observed to colocalize with macrophage marker CD68, suggesting that immune cells were direct targets of SARS-CoV-2. Additionally, using RNAscope, the presence of viral RNA was also detected.\u00a0Our positive finding in the breast tissue is corroborated by the recent reports of immunocompromised patients experiencing LC symptoms and persistent viral replication.\u00a0Overall, our findings and emerging LC studies raise the possibility that the gastrointestinal tract may function as a reservoir for SARS-CoV-2.<\/jats:p>","DOI":"10.3389\/fimmu.2022.939989","type":"journal-article","created":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T05:28:08Z","timestamp":1662355688000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":46,"title":["Case report: Persistence of residual antigen and RNA of the SARS-CoV-2 virus in tissues of two patients with long COVID"],"prefix":"10.3389","volume":"13","author":[{"given":"Denise","family":"Goh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey Chun Tatt","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia Bilbao","family":"Ferna\u00edndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig Ryan","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara Gil","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen Wei","family":"Neo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justina Nadia","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00edlvia Guerrero","family":"Caballero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai Chan","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe Poh Sheng","family":"Yeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(21)00703-9","article-title":"Condition WHOCCDWGoP-c-. a clinical case definition of post-COVID-19 condition by a Delphi consensus","volume":"3099","author":"Soriano","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2021-324622","article-title":"Gut as viral reservoir: lessons from gut viromes, HIV and COVID-19","volume":"70","author":"Neurath","year":"2021","journal-title":"Gut"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2021-324090","article-title":"Six-month follow-up of gut microbiota richness in patients with COVID-19","volume":"71","author":"Chen","year":"2022","journal-title":"Gut"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1009037","article-title":"On the whereabouts of SARS-CoV-2 in the human body: A systematic review","volume":"16","author":"Trypsteen","year":"2020","journal-title":"PLoS Pathogens"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1126\/science.abc1669","article-title":"SARS-CoV-2 productively infects human gut enterocytes","volume":"369","author":"Lamers","year":"2020","journal-title":"Science"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2021-324280","article-title":"Residual SARS-CoV-2 viral antigens detected in GI and hepatic tissues from five recovered patients with COVID-19","volume":"71","author":"Cheung","year":"2022","journal-title":"Gut"},{"key":"B7","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1186\/s12876-021-01905-3","article-title":"SARS-CoV-2 identified by transmission electron microscopy in lymphoproliferative and ischaemic intestinal lesions of COVID-19 patients with acute abdominal pain: two case reports","volume":"21","author":"Martin-Cardona","year":"2021","journal-title":"BMC Gastroenterol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1136\/gutjnl-2020-320953","article-title":"Digestive system is a potential route of COVID-19: an analysis of single-cell coexpression pattern of key proteins in viral entry process","volume":"69","author":"Zhang","year":"2020","journal-title":"Gut"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2022.04.037","article-title":"Postacute COVID-19 is characterized by gut viral antigen persistence in inflammatory bowel diseases","volume":"163","author":"Zollner","year":"2022","journal-title":"Gastroenterology"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-022-00611-z","article-title":"Gastrointestinal post-acute COVID-19 syndrome","volume":"19","author":"Meringer","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.52216.1","article-title":"Global prevalence of prolonged gastrointestinal symptoms in COVID-19 survivors and potential pathogenesis: A systematic review and meta-analysis","volume":"10","author":"Yusuf","year":"2021","journal-title":"F1000Res"},{"key":"B12","doi-asserted-by":"publisher","first-page":"06","DOI":"10.1101\/2021.06.09.21258553","article-title":"Analysis of cell-mediated immunity in people with long COVID","volume":"2021","author":"Montes","year":"2021","journal-title":"medRxiv"},{"key":"B13","article-title":"Media statement from  director Rochelle p. walensky, MD, MPH, on signing the advisory committee on immunization practices\u2019 recommendation for an additional dose of an mRNA COVID-19 vaccine in moderately to severely immunocompromised people","year":"2021"},{"key":"B14","doi-asserted-by":"publisher","first-page":"jiab622","DOI":"10.1101\/2021.10.02.21264267","article-title":"Year-long COVID-19 infection reveals within-host evolution of SARS-CoV-2 in a patient with b cell depletion","author":"Nussenblatt","year":"2021","journal-title":"J Infect Dis"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa446","article-title":"Persistent COVID-19 in an immunocompromised patient temporarily responsive to two courses of remdesivir therapy","volume":"222","author":"Helleberg","year":"2020","journal-title":"J Infect Dis"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2021.10.045","article-title":"COVID-19 in an immunocompromised host: persistent shedding of viable SARS-CoV-2 and emergence of multiple mutations: a case report","volume":"114","author":"Leung","year":"2022","journal-title":"Int J Infect Dis"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.pathol.2017.11.087","article-title":"An automated staining protocol for seven-colour immunofluorescence of human tissue sections for diagnostic and prognostic use","volume":"50","author":"Lim","year":"2018","journal-title":"Pathology"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-000987","article-title":"Immunohistochemical scoring of CD38 in the tumor microenvironment predicts responsiveness to anti-PD-1\/PD-L1 immunotherapy in hepatocellular carcinoma","volume":"8","author":"Ng","year":"2020","journal-title":"J Immunother Cancer"},{"key":"B19","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s40425-019-0499-y","article-title":"Prognostic value of CD8\u2009+\u2009PD-1+ immune infiltrates and PDCD1 gene expression in triple negative breast cancer","volume":"7","author":"Yeong","year":"2019","journal-title":"J ImmunoTher Cancer"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01209","article-title":"High densities of tumor-associated plasma cells predict improved prognosis in triple negative breast cancer","volume":"9","author":"Yeong","year":"2018","journal-title":"Front Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmoldx.2011.08.002","article-title":"RNAscope: a novel in situ RNA analysis platform for formalin-fixed, paraffin-embedded tissues","volume":"14","author":"Wang","year":"2012","journal-title":"J Mol Diagn"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1126\/science.abc4776","article-title":"SARS-CoV-2 infection protects against rechallenge in rhesus macaques","volume":"369","author":"Chandrashekar","year":"2020","journal-title":"Sci (New York NY)"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-1070-6","article-title":"Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamsters","volume":"26","author":"Tostanoski","year":"2020","journal-title":"Nat Med"}],"updated-by":[{"DOI":"10.3389\/fimmu.2022.1036894","type":"corrigendum","label":"Corrigendum","source":"publisher","updated":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T00:00:00Z","timestamp":1665014400000}}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.939989\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T13:37:50Z","timestamp":1665063470000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.939989\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,5]]},"references-count":23,"alternative-id":["10.3389\/fimmu.2022.939989"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.939989","relation":{"corrigendum":[{"id-type":"doi","id":"10.3389\/fimmu.2022.1036894","asserted-by":"object"}]},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,5]]},"article-number":"939989"}}